DXCM 69.55 (-0.5%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - DXCM ranking 42 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by linearity 10 years
1. Neogen NEOG
62.56
2. Inotiv NOTV
39.82
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Illumina ILMN
33.06
5. Guardant Health GH
18.21
6. National Research NRC
15.89
7. Olink Holding OLK
8.11
8. Pacific Biosciences of California PACB
6.18
9. Myriad Genetics MYGN
5.95
10. Global Cord Blood CO
5.67
11. DarioHealth DRIO
4.86
12. Sotera Health SHC
4.75
13. Fulgent Genetics FLGT
4.6
14. Bioventus BVS
4.27
15. Anixa Biosciences ANIX
4.18
16. Syneos Health SYNH
3.71
17. Sera Prognostics SERA
3.6
18. Co-Diagnostics CODX
3.31
19. NeoGenomics NEO
3.15
20. Enzo Biochem ENZ
3.08
21. Psychemedics PMD
2.91
22. Qiagen QGEN
2.63
23. Twist Bioscience TWST
2.45
24. Aspira Womens Health AWH
2.28
25. Exagen XGN
2.22
26. Meridian Bioscience VIVO
2.1
27. MDxHealth MDXH
2.05
28. Biodesix BDSX
2
29. MaxCyte MXCT
1.91
30. Personalis PSNL
1.88
31. Prenetics Global PRE
1.8
32. bioAffinity Technologies BIAF
1.79
33. Organovo Holdings ONVO
1.66
34. Neuronetics STIM
1.62
35. Exact Sciences EXAS
1.59
36. Charles River Laboratories CRL
1.57
37. Trinity Biotech TRIB
1.57
38. Laboratory Corp of America Holdings LH
1.46
39. Quest Diagnostics DGX
1.45
40. SeqLL SQL
1.42
41. Interpace Biosciences IDXG
1.31
42. DexCom DXCM
1.15
43. PerkinElmer PKI
1.15
44. CareDx CDNA
1.12
45. Precipio PRPO
1.09
46. Waters WAT
0.76
47. IQVIA Holdings IQV
0.72
48. Agilent Technologies A
0.7
49. Heska HSKA
0.52
50. IDEXX Laboratories IDXX
0.46
51. Mettler-Toledo MTD
0.42
52. RadNet RDNT
0.42
53. Thermo Fisher Scientific TMO
0.42
54. Natera NTRA
0.41
55. Lantheus Holdings LNTH
0.41
56. Icon ICLR
0.36
57. Danaher DHR
0.36
58. Medpace Holdings MEDP
0.24

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.